Covid Plan B
covidplanb.co.nz
A WHO-commissioned meta-analysis of Ivermectin shows that using this generic medicine in hospitals leads to a 83% reduction in covid mortality (95% CI 65%-92%).
The WHO is understood to be waiting for the results this month from three trials before issuing a recommendation. The position of NZ’s Ministry of Health cautioning against using Ivermectin has not changed since April 2020, despite consistent growth in studies showing effectiveness.
On the basis of the studies to date, Covid Plan B urges the Ministry of Health to immediately delete its nine-month-old caution against using Ivermectin to treat COVID-19.
A new formal position can be released following advice from the WHO. Internationally, front line doctors have been frustrated and even abused by authorities and politicians in their efforts trying to make people aware of the effectiveness of Ivermectin.
Testimony Kory 2020-12-08 by Juana Atkins on Scribd
https://www.hsgac.senate.gov/imo/media/doc/Testimony-Kory-2020-12-08.pdf
Covid Plan B contrasts the MOH warning against studies that emerged in favour of Ivermectin, with its decision to buy respirators at the start of the pandemic without clear evidence of their effectiveness.
It now appears that respirators harmed some COVID-19 patients. Panic from politicians and policymakers has driven over-reactions and bad decisions. Acting without evidence has caused more harm than good.
Please share this article so that others can discover The BFD.